¼¼°èÀÇ Á¾¾ç ¿µ¾çÇÐ ½ÃÀå
Oncology Nutrition
»óǰÄÚµå : 1760994
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 352 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,124,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,373,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¾¾ç ¿µ¾çÇÐ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 25¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 15¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Á¾¾ç ¿µ¾çÇÐ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 9.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 25¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ µÎ°æºÎ´Â CAGR 8.5%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 6¾ï 960¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À§¡¤¼ÒÈ­±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 11.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 2,190¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Á¾¾ç ¿µ¾çÇÐ ½ÃÀåÀº 2024³â¿¡´Â 5¾ï 2,190¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2¾ï 5,450¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 8.4%¿Í 7.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 9.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Á¾¾ç ¿µ¾çÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¾¾ç ¿µ¾çÇÐÀ̶õ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

Á¾¾ç ¿µ¾çÇÐÀº ¾ÏȯÀÚÀÇ Æ¯º°ÇÑ ½Ä»ýȰ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾î Áõ»ó °ü¸®¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¾Ï°ú ±× Ä¡·á´Â ȯÀÚÀÇ ½Ä»ç ´É·Â°ú ¿µ¾ç Èí¼ö ´É·Â¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ ¿µ¾çÀº ¾Ï Ä¡·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀûÀýÇÑ ¿µ¾ç °ü¸®´Â ü·Â À¯Áö, °¨¿° À§Çè °¨¼Ò, »îÀÇ Áú Çâ»ó, ȸº¹ ¼Óµµ Çâ»ó¿¡ µµ¿òÀÌ µË´Ï´Ù. ¿©±â¿¡´Â ƯÁ¤ ¿µ¾ç °áÇÌÀ» ÇØ°áÇϰí, ¸Þ½º²¨¿òÀ̳ª üÁß °¨¼Ò¿Í °°Àº Ä¡·á ºÎÀÛ¿ëÀ» °ü¸®Çϸç, Ä¡·á Áß ¹× Ä¡·á ÈÄ ½ÅüÀÇ ¸é¿ª ü°è¿Í Àü¹ÝÀûÀÎ °Ç°­À» Áö¿øÇÏ´Â ¸ÂÃãÇü ½Ä´Ü °èȹÀÌ Æ÷ÇԵ˴ϴÙ.

¿¬±¸´Â Á¾¾ç ¿µ¾çÇÐ ½Ç¹«¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?

Á¾¾ç ¿µ¾çÇÐÀÇ Áö¼ÓÀûÀÎ ¿¬±¸·Î ƯÁ¤ ½Äǰ°ú ¿µ¾ç¼Ò°¡ Á¾¾çÀÇ ¼ºÀå, ȯÀÚÀÇ È¸º¹·Â, Ä¡·á È¿°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀÌÇØ´Â Á¡Á¡ ´õ ±í¾îÁö°í ÀÖ½À´Ï´Ù. Ä¡·á·Î ÀÎÇØ È­Çпä¹ýÀ¸·Î ÀÎÇÑ ¸Þ½º²¨¿òÀ̳ª ¹æ»ç¼± Ä¡·á·Î ÀÎÇÑ Ã¼Áß °¨¼Ò¿Í °°Àº ¾Ï Ä¡·áÀÇ ºÎÀÛ¿ëÀ» ÁÙÀÏ ¼ö Àִ ƯÁ¤ ¿µ¾ç Àü·«ÀÌ È®Àεǰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿À¸Þ°¡ 3 Áö¹æ»êÀº ¾Ï ȯÀÚÀÇ ±ÙÀ°·®À» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â °ÍÀ¸·Î ¹àÇôÁ³À¸¸ç, °úÀϰú ä¼Ò¿¡ ÇÔÀ¯µÈ Ç×»êÈ­Á¦´Â È­Çпä¹ýÀ¸·Î ÀÎÇÑ »êÈ­ ½ºÆ®·¹½º¸¦ °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸¿Í °³¹ßÀº ¾Ï Ä¡·á¿¡ ÀÖ¾î º¸´Ù È¿°úÀûÀÌ°í ±Ù°Å¿¡ ±â¹ÝÇÑ ¿µ¾ç Áöħ°ú °³ÀÔÀÇ °³¹ßÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Á¾¾ç ¿µ¾çÇп¡¼­ ÀÇ·á Àü¹®°¡´Â ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

¾Ï Àü¹®ÀÇ, ¿µ¾ç»ç, ¿µ¾ç»ç¿Í °°Àº ÀÇ·á Àü¹®°¡´Â ¾Ï Ä¡·á¿¡ ¿µ¾çÀ» ÅëÇÕÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. À̵éÀº Çù·ÂÇÏ¿© ȯÀÚÀÇ ¿µ¾ç »óŸ¦ Æò°¡Çϰí, ¸ÂÃãÇü ¿µ¾ç °èȹÀ» ¼ö¸³Çϰí, Ä¡·á ÁøÇà¿¡ µû¶ó ÀÌ·¯ÇÑ °èȹÀ» Á¶Á¤ÇÕ´Ï´Ù. ÀÌ Àü¹®°¡µéÀÌ Á¦°øÇÏ´Â ±³À°Àº ȯÀÚ¿Í °£º´ÀÎÀÌ ¾Ï Ä¡·á Áß ½Ä´Ü ¼±Åðú ½Ä½À°ü¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ±×µéÀÇ Àü¹® Áö½ÄÀº ¿µ¾ç Àü·«ÀÌ Ä¡·á ¸ñÇ¥¿¡ ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ºÎÇÕÇϵµ·Ï ÇÏ¿© ȯÀÚÀÇ °á°ú¿Í ¿µ¾ç ±ÇÀå »çÇ× Áؼö¸¦ ÃÖÀûÈ­ÇÕ´Ï´Ù.

Á¾¾ç ¿µ¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Á¾¾ç ¿µ¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡, ¿µ¾ç°ú ¾Ï ȸº¹ÀÇ ¿¬°ü¼º¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿µ¾ç ¿¬±¸ÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÇÔ²² ¾Ï ȯÀÚ ¼ö´Â °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾Ï ȯÀÚ¸¦ Áö¿øÇϱâ À§ÇÑ Àü¹®ÀûÀÎ ¿µ¾ç Àü·«¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ä½À°üÀÌ Ä¡·á È¿°ú¿Í ȯÀÚÀÇ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Àüü ¾Ï Ä¡·á °èȹ¿¡ ¿µ¾ç °ü¸®¸¦ ÅëÇÕÇÏ´Â °Í¿¡ ´ëÇÑ Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ¿µ¾ç Æò°¡ µµ±¸ÀÇ ±â¼úÀû ¹ßÀü°ú ¿µ¾ç¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí È¿°úÀûÀÎ ½Çõ ¹æ¹ý¿¡ ´ëÇÑ ÀÌÇØ¿Í ½ÇÇàÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¾ÏÁ¾(µÎ°æºÎ, À§¡¤¼ÒÈ­±â, ÃéÀå, À¯¹æ, °£, ±âŸ ¾ÏÁ¾), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ÀçÅà Äɾî, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 31°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Oncology Nutrition Market to Reach US$2.5 Billion by 2030

The global market for Oncology Nutrition estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Head & Neck, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$521.9 Million While China is Forecast to Grow at 11.5% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$521.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Oncology Nutrition Market - Key Trends & Drivers Summarized

What Is Oncology Nutrition and Why Is It Critical?

Oncology nutrition focuses on meeting the unique dietary needs of cancer patients to help manage symptoms and improve treatment outcomes. Nutrition plays a pivotal role in oncology because cancer and its treatments can significantly affect the patient's ability to eat and absorb nutrients. Proper nutritional care can help maintain body strength, decrease infection risks, improve quality of life, and enhance recovery rates. It involves personalized diet plans that address specific nutritional deficiencies, manage treatment side effects like nausea and weight loss, and support the body’s immune system and overall health during and after treatment.

How Does Research Influence Oncology Nutrition Practices?

Continuous research in oncology nutrition has deepened understanding of how certain foods and nutrients affect tumor growth, patient resilience, and treatment response. Studies have identified specific nutritional strategies that can mitigate the side effects of cancer treatments, such as chemotherapy-induced nausea or radiation-induced weight loss. For instance, omega-3 fatty acids are found to help preserve muscle mass in cancer patients, while antioxidants in fruits and vegetables may reduce the oxidative stress caused by chemotherapy. This growing body of research supports the development of more effective, evidence-based nutritional guidelines and interventions for cancer care.

What Role Do Healthcare Professionals Play in Oncology Nutrition?

Healthcare professionals, including oncologists, dietitians, and nutrition specialists, play a crucial role in integrating nutrition into cancer care. They work collaboratively to assess the nutritional status of patients, devise customized nutrition plans, and adjust these plans as treatment progresses. Education provided by these professionals is vital, as it empowers patients and caregivers to make informed decisions about food choices and dietary habits during cancer treatment. Their expertise ensures that nutritional strategies are safely and effectively aligned with therapeutic goals, thereby optimizing patient outcomes and adherence to nutrition recommendations.

What Drives the Growth in the Oncology Nutrition Market?

The growth in the oncology nutrition market is driven by several factors, including rising global cancer incidence rates, growing awareness of the link between nutrition and cancer recovery, and advancements in nutritional research. As the global population ages, the number of cancer cases continues to climb, increasing the demand for specialized nutritional strategies to support oncology patients. Moreover, as patients and healthcare providers become more aware of how diet impacts treatment efficacy and patient quality of life, there is a greater emphasis on integrating tailored nutritional care into overall cancer treatment plans. Technological advancements in nutritional assessment tools and increased investment in nutrition-focused research further fuel market growth, enhancing the understanding and implementation of effective oncology nutrition practices.

SCOPE OF STUDY:

The report analyzes the Oncology Nutrition market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Cancer Type (Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver, Other Cancer Types); End-Use (Hospitals, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 31 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â